ENO1 and breast carcinoma: In breast cancer, ENO1’s role can be context-dependent: in early-stage breast cancer, higher ENO1 expression correlates with better survival and increased anti-tumor immune infiltration, while in advanced disease, it is associated with progression and immune evasion [74].